ArticleBMC medical imaging2025
Parameter efficient fine-tunning of foundation model to facilitate tumor response prediction for ovarian cancer patients.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn clinical practice, it is critically important to predict the tumor response of chemotherapy at an early stage. However, the performance of existing clinical markers cannot achieve satisfactory accuracy and reliability. To overcome this limitation, in this study we proposed a foundation model based approach to improve prediction performance.
methodsWe adopted a CLIP (Contrastive language-image pretraining) based foundation model, which contains a total of 12 transformer layers for both image and textual encoders. This model has been extensively pretrained on a non-medical image-text dataset. Meanwhile, a parameter efficient low rank adaptor (LoRA) was incorporated into the transformer layers for fine-tuning purpose. The adaptors were inserted at various layers of both encoders, and their corresponding performances were evaluated and compared. The experiments were conducted on a retrospective dataset containing a total of 182 advanced stage ovarian cancer cases, among which 124 were responders and 58 were non-responders.
resultsThe best performance was achieved by adding LoRA adaptors on the lowest 5 transformer layers for both image and textual encoders, which yields an AUC (area under the receiver operating characteristic curve) of 0.785 ± 0.039 and an ACC (accuracy) of 0.780 ± 0.032. As a comparison, the conventional transfer learning strategy fine-tuned ResNet and ViT models achieved AUCs of 0.754 ± 0.089 and 0.707 ± 0.079, respectively.
conclusionThis study initially demonstrates the feasibility of parameter efficient training with a foundation model for chemotherapy response prediction, highlighting its potential to support clinical decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.